(Q35214489)

7 August 2017

1 reference

title

Complications of second and third trimester pregnancies (English)

1 reference

7 August 2017

Kelly Abbrescia

1

1 reference

7 August 2017

Barry Sheridan

series ordinal

2

1 reference

7 August 2017

publication date

1 August 2003

1 reference

Emergency medicine clinics of North America

7 August 2017

published in

1 reference

7 August 2017

volume

21

1 reference

7 August 2017

issue

3

1 reference

7 August 2017

page(s)

695-710, vii

1 reference

Preterm labor: its diagnosis and management

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2803%2900043-9

7 January 2021

Tocolytics for preterm labor: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2803%2900043-9

7 January 2021

Magnesium sulfate as a tocolytic agent

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2803%2900043-9

7 January 2021

Oral nicardipine versus intravenous magnesium sulfate for the treatment of preterm labor.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2803%2900043-9

7 January 2021

The effect of the oxytocin antagonist atosiban on preterm uterine activity in the human.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2803%2900043-9

7 January 2021

Treatment of preterm labor with the oxytocin antagonist atosiban

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2803%2900043-9

7 January 2021

Premature rupture of the fetal membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2803%2900043-9

7 January 2021

Infection and Preterm Labor

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2803%2900043-9

7 January 2021

Preterm premature rupture of the membranes: a risk factor for the development of abruptio placentae

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2803%2900043-9

7 January 2021

Management of preterm premature rupture of membranes: lack of a national consensus

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2803%2900043-9

7 January 2021

Neonatal sepsis after betamethasone administration to patients with preterm premature rupture of membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2803%2900043-9

7 January 2021

Tocolytic therapy in preterm PROM

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2803%2900043-9

7 January 2021

Antibiotic therapy in preterm premature rupture of membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2803%2900043-9

7 January 2021

Expanded-spectrum antibiotics with preterm premature rupture of membranes.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2803%2900043-9

7 January 2021

Antibiotic therapy for reduction of infant morbidity after preterm premature rupture of the membranes. A randomized controlled trial. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2803%2900043-9

7 January 2021

Histologic chorioamnionitis, antenatal steroids, and perinatal outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2803%2900043-9

7 January 2021

Chorioamnionitis as a risk factor for cerebral palsy: A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2803%2900043-9

7 January 2021

Chorioamnionitis and uterine function.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2803%2900043-9

7 January 2021

The aetiology and outcome of abruptio placentae

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2803%2900043-9

7 January 2021

Severity of abruptio placentae and neurodevelopmental outcome in low birth weight infants.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2803%2900043-9

7 January 2021

Placental abruption associated with cocaine abuse.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2803%2900043-9

7 January 2021

Genesis of severe placental abruption

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2803%2900043-9

7 January 2021

Is tocolysis safe in the management of third-trimester bleeding?

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2803%2900043-9

7 January 2021

Clinical significance of placenta previa detected at early routine transvaginal scan.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2803%2900043-9

7 January 2021

The epidemiology of placenta previa in the United States, 1979 through 1987.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2803%2900043-9

7 January 2021

Previous cesarean section and abortion as risk factors for developing placenta previa

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2803%2900043-9

7 January 2021

High incidence of respiratory distress syndrome (RDS) in infants born to mothers with placenta previa

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2803%2900043-9

7 January 2021

Maternal complications with placenta previa

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2803%2900043-9

7 January 2021

Circumvallate and circummarginate placentas. Their incidence and clinical significance

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2803%2900043-9

7 January 2021

Vasa previa: prenatal diagnosis, natural evolution, and clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2803%2900043-9

7 January 2021

An accurate antenatal diagnosis of vasa previa with transvaginal color Doppler ultrasonography

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2803%2900043-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2803%2900043-9

7 January 2021

Causes of perinatal death associated with gestational hypertension and proteinuria

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2803%2900043-9

7 January 2021

Eclampsia. VI. Maternal-perinatal outcome in 254 consecutive cases

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2803%2900043-9

7 January 2021

Altered blood pressure course during normal pregnancy and increased preeclampsia at high altitude (3100 meters) in Colorado

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2803%2900043-9

7 January 2021

MOS HIP: McMaster outcome study of hypertension in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2803%2900043-9

7 January 2021

Magnesium sulfate therapy in certain emergency conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2803%2900043-9

7 January 2021

A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2803%2900043-9

7 January 2021

Magnesium sulfate therapy in preeclampsia and eclampsia.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2803%2900043-9

7 January 2021

Pregnancy complicated by pre-eclampsia-eclampsia with HELLP syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2803%2900043-9

7 January 2021

10.1016/S0733-8627(03)00043-9

Identifiers

DOI

1 reference

7 August 2017

1 reference